These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11724658)

  • 1. Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium.
    Gentry CC; Okolo SO; Fong LF; Crow JC; Maclean AB; Perrett CW
    Clin Sci (Lond); 2001 Dec; 101(6):691-5. PubMed ID: 11724658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
    Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
    Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
    Luo X; Levens E; Williams RS; Chegini N
    Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
    Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
    Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
    Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas.
    Poncelet C; Fauvet R; Feldmann G; Walker F; Madelenat P; Darai E
    J Surg Oncol; 2004 May; 86(2):84-90. PubMed ID: 15112250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas.
    Di Lieto A; De Falco M; Pollio F; Mansueto G; Salvatore G; Somma P; Ciociola F; De Rosa G; Staibano S
    J Soc Gynecol Investig; 2005 Feb; 12(2):123-8. PubMed ID: 15695108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor mRNA in human leiomyomas.
    Lewicka A; Osuch B; Cendrowski K; Zegarska J; Stelmachów J
    Gynecol Endocrinol; 2010 Jun; 26(6):451-5. PubMed ID: 20443739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern.
    Di Lieto A; De Falco M; Mansueto G; De Rosa G; Pollio F; Staibano S
    Steroids; 2005 Feb; 70(2):95-102. PubMed ID: 15631865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium.
    van de Ven J; Donker TH; Blankenstein MA; Thijssen JH
    Fertil Steril; 2002 Jun; 77(6):1227-32. PubMed ID: 12057733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas.
    Korompelis P; Piperi C; Adamopoulos C; Dalagiorgou G; Korkolopoulou P; Sepsa A; Antsaklis A; Papavassiliou AG
    Clin Chem Lab Med; 2015 Aug; 53(9):1415-24. PubMed ID: 25470608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An accumulation of insulin-like growth factor I (IGF-I) in human myometrium and uterine leiomyomas in various stages of tumour growth.
    Wolańska M; Bańkowski E
    Eur Cytokine Netw; 2004; 15(4):359-63. PubMed ID: 15627646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the expression of vascular endothelial growth factor in patients with adenomyosis of the uterus].
    Han Y; Zhou Y; Zheng S
    Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):539-41. PubMed ID: 12411015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
    Levens E; Luo X; Ding L; Williams RS; Chegini N
    Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
    Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of bcl-2 protein in uterine leiomyomas and normal myometrium].
    Zhang ZL; Zhang Y; Xu BQ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):363-5. PubMed ID: 12536738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.
    Wolańska M; Bańkowski E
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):238-44. PubMed ID: 16564125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.